Israel Englander Silverback Therapeutics, Inc. Transaction History

Millennium Management LLC

  • $224 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
N/A
950,044 Added 380.91%
1,199,456 $0
Q1 2023

May 15, 2023
BUY
N/A
217,711 Added 686.76%
249,412 $1.62 Million
Q4 2022

Feb 14, 2023
SELL
$0.0 - $6.07 $0 - $1.93 Million
-317,579 Reduced 90.92%
31,701 $270,000
Q3 2022

Nov 14, 2022
SELL
$3.91 - $5.52 $413,564 - $583,855
-105,771 Reduced 23.24%
349,280 $1.84 Million

Others Institutions Holding SBTX

# of Institutions
117
Shares Held
47.9M
Call Options Held
442K
Put Options Held
42K
View Full List

About Silverback Therapeutics, Inc.

SBTX Quotes by TradingView
  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email